A detailed history of Ubs Asset Management Americas Inc transactions in Organon & Co. stock. As of the latest transaction made, Ubs Asset Management Americas Inc holds 836,389 shares of OGN stock, worth $12.8 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares
836,389
Previous 832,360 0.48%
Holding current value
$12.8 Million
Previous $17.2 Million 7.13%
% of portfolio
0.0%
Previous 0.0%

Shares

13 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

BUY
$18.65 - $23.03 $75,140 - $92,787
4,029 Added 0.48%
836,389 $16 Million
Q2 2024

Aug 13, 2024

BUY
$17.45 - $21.96 $6.51 Million - $8.19 Million
372,789 Added 81.12%
832,360 $17.2 Million
Q1 2024

May 15, 2024

SELL
$13.78 - $18.8 $105,279 - $143,632
-7,640 Reduced 1.64%
459,571 $8.64 Million
Q4 2023

Feb 14, 2024

SELL
$10.95 - $17.32 $559,030 - $884,237
-51,053 Reduced 9.85%
467,211 $6.74 Million
Q3 2023

Nov 13, 2023

SELL
$16.59 - $23.77 $2.3 Million - $3.29 Million
-138,504 Reduced 21.09%
518,264 $9 Million
Q1 2023

May 15, 2023

BUY
$21.42 - $32.08 $278,095 - $416,494
12,983 Added 2.02%
656,768 $15.4 Million
Q4 2022

Feb 14, 2023

BUY
$23.31 - $28.61 $487,412 - $598,235
20,910 Added 3.36%
643,785 $18 Million
Q3 2022

Nov 14, 2022

SELL
$23.4 - $34.25 $1.58 Million - $2.32 Million
-67,692 Reduced 9.8%
622,875 $14.6 Million
Q2 2022

Aug 12, 2022

BUY
$31.66 - $38.9 $1.35 Million - $1.65 Million
42,485 Added 6.56%
690,567 $23.3 Million
Q1 2022

May 16, 2022

BUY
$30.45 - $39.36 $774,404 - $1 Million
25,432 Added 4.08%
648,082 $22.6 Million
Q4 2021

Feb 14, 2022

BUY
$28.67 - $37.13 $808,780 - $1.05 Million
28,210 Added 4.75%
622,650 $19 Million
Q3 2021

Nov 15, 2021

BUY
$28.63 - $35.64 $436,951 - $543,937
15,262 Added 2.64%
594,440 $19.5 Million
Q2 2021

Aug 16, 2021

BUY
$28.45 - $38.0 $16.5 Million - $22 Million
579,178 New
579,178 $17.5 Million

Others Institutions Holding OGN

About Organon & Co.


  • Ticker OGN
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 254,330,000
  • Market Cap $3.89B
  • Description
  • Organon & Co., a health care company, develops and delivers health solutions through a portfolio of prescription therapies in the United States and internationally. Its women's health portfolio comprises contraception and fertility brands, such as Nexplanon/Implanon, a long-acting reversible contraceptive. The company's biosimilars portfolio...
More about OGN
Track This Portfolio

Track Ubs Asset Management Americas Inc Portfolio

Follow Ubs Asset Management Americas Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Ubs Asset Management Americas Inc, based on Form 13F filings with the SEC.

News

Stay updated on Ubs Asset Management Americas Inc with notifications on news.